Publication: Drug-resistant tuberculosis: Pediatric guidelines
Issued Date
2011-01-01
Resource Type
ISSN
15320987
08913668
08913668
Other identifier(s)
2-s2.0-79957998404
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pediatric Infectious Disease Journal. Vol.30, No.6 (2011), 501-505
Suggested Citation
Mona Al-Dabbagh, Keswadee Lapphra, Rumi McGloin, Kelsey Inrig, H. Simon Schaaf, Ben J. Marais, Laura Sauve, Ian Kitai, Tobias R. Kollmann Drug-resistant tuberculosis: Pediatric guidelines. Pediatric Infectious Disease Journal. Vol.30, No.6 (2011), 501-505. doi:10.1097/INF.0b013e31820b583d Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12775
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Drug-resistant tuberculosis: Pediatric guidelines
Abstract
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. Copyright © 2011 by Lippincott Williams & Wilkins.